开云app官网登录入口网页版-官方正版

#非瓣膜性#

41篇内容 | 1153人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1819495, encodeId=f826181949546, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=BMJ：心脏复律可降低新诊断非瓣膜性房颤患者不良预后风险, objectType=article, longId=219448, objectId=7088219448e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7088219448e5, replyNumber=0, likeNumber=96, createdTime=2022-01-17, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7088219448e5, moduleTitle=BMJ：心脏复律可降低新诊断非瓣膜性房颤患者不良预后风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7088219448e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819496, encodeId=ae431819496a3, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=J Cardiol：非瓣膜性心房颤动合并急性心力衰竭患者使用艾多沙班治疗的D-二聚体水平变化分析, objectType=article, longId=295735, objectId=5c33295e3598, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c33295e3598, replyNumber=0, likeNumber=83, createdTime=2022-05-27, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c33295e3598, moduleTitle=J Cardiol：非瓣膜性心房颤动合并急性心力衰竭患者使用艾多沙班治疗的D-二聚体水平变化分析, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5c33295e3598)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819491, encodeId=e3bc1819491b9, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=Eur Heart J：非瓣膜性房颤患者持续服用口服抗凝药的预测因子、时间进程和结局, objectType=article, longId=214455, objectId=7be82144553e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7be82144553e, replyNumber=0, likeNumber=78, createdTime=2021-09-19, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7be82144553e, moduleTitle=Eur Heart J：非瓣膜性房颤患者持续服用口服抗凝药的预测因子、时间进程和结局, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7be82144553e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819489, encodeId=5c02181948912, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=JAHA：血压变异性对非瓣膜性房颤患者不良事件的影响, objectType=article, longId=205054, objectId=cefe2050546c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cefe2050546c, replyNumber=0, likeNumber=74, createdTime=2021-03-05, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cefe2050546c, moduleTitle=JAHA：血压变异性对非瓣膜性房颤患者不良事件的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cefe2050546c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819494, encodeId=35bc1819494e3, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=Br J Clin Pharmacol：非瓣膜性房颤遇上肝病，直接口服抗凝剂的使用和长期疗效, objectType=article, longId=217659, objectId=afdf21e659f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afdf21e659f3, replyNumber=0, likeNumber=63, createdTime=2022-05-20, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afdf21e659f3, moduleTitle=Br J Clin Pharmacol：非瓣膜性房颤遇上肝病，直接口服抗凝剂的使用和长期疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=afdf21e659f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819493, encodeId=fa6a181949380, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=2021 ESC：利伐沙班显著降低肾功能保留的非瓣膜性房颤患者的肾功能下降风险, objectType=article, longId=216628, objectId=47192166282f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47192166282f, replyNumber=0, likeNumber=78, createdTime=2022-04-10, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47192166282f, moduleTitle=2021 ESC：利伐沙班显著降低肾功能保留的非瓣膜性房颤患者的肾功能下降风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=47192166282f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819492, encodeId=f1f61819492a9, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=对于非瓣膜性房颤使用新型抗凝药物的用量如何确定？, objectType=article, longId=214673, objectId=3ca32146e3e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ca32146e3e5, replyNumber=0, likeNumber=65, createdTime=2022-04-30, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ca32146e3e5, moduleTitle=对于非瓣膜性房颤使用新型抗凝药物的用量如何确定？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3ca32146e3e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819490, encodeId=95ba1819490a9, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=JACC：糖尿病前期也可增加非瓣膜性房颤患者的卒中风险, objectType=article, longId=207827, objectId=3f7620e82759, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f7620e82759, replyNumber=0, likeNumber=62, createdTime=2021-11-12, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f7620e82759, moduleTitle=JACC：糖尿病前期也可增加非瓣膜性房颤患者的卒中风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3f7620e82759)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819487, encodeId=9864181948e91, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=Stroke：非瓣膜性房颤患者卒中发作后早期开始直接口服抗凝药对短期和长期结局的影响, objectType=article, longId=186699, objectId=44a91866995e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44a91866995e, replyNumber=0, likeNumber=89, createdTime=2020-05-31, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44a91866995e, moduleTitle=Stroke：非瓣膜性房颤患者卒中发作后早期开始直接口服抗凝药对短期和长期结局的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=44a91866995e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819488, encodeId=823e181948818, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=EUR HEART J-CARD PHA：利伐沙班与华法林对非瓣膜性心房颤动和冠状动脉或外周动脉疾病患者的有效性和安全性如何？, objectType=article, longId=198584, objectId=2f96198584fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f96198584fb, replyNumber=0, likeNumber=58, createdTime=2021-07-08, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f96198584fb, moduleTitle=EUR HEART J-CARD PHA：利伐沙班与华法林对非瓣膜性心房颤动和冠状动脉或外周动脉疾病患者的有效性和安全性如何？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2f96198584fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819485, encodeId=1bb518194858f, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=2019 ESO指南：卒中或短暂性脑缺血发作以及非瓣膜性房颤患者卒中和其他血栓栓塞事件二级预防抗栓治疗, objectType=article, longId=165554, objectId=60da165554b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60da165554b1, replyNumber=0, likeNumber=53, createdTime=2019-07-01, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60da165554b1, moduleTitle=2019 ESO指南：卒中或短暂性脑缺血发作以及非瓣膜性房颤患者卒中和其他血栓栓塞事件二级预防抗栓治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=60da165554b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819486, encodeId=b47518194869c, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=Chest：非瓣膜性房颤患者四种口服抗凝血剂的有效性和安全性评估, objectType=article, longId=166308, objectId=02b116630814, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02b116630814, replyNumber=0, likeNumber=87, createdTime=2020-03-22, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02b116630814, moduleTitle=Chest：非瓣膜性房颤患者四种口服抗凝血剂的有效性和安全性评估, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=02b116630814)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819484, encodeId=51af181948430, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=2019ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS适用性标准：非瓣膜性心脏病心脏结构和功能多峰成像评估, objectType=article, longId=158248, objectId=3c941582481a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c941582481a, replyNumber=0, likeNumber=90, createdTime=2019-06-25, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c941582481a, moduleTitle=2019ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS适用性标准：非瓣膜性心脏病心脏结构和功能多峰成像评估, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3c941582481a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819482, encodeId=05181819482d5, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=Stroke：非瓣膜性心房颤动患者口服抗凝剂的有效性和安全性研究, objectType=article, longId=155912, objectId=379b1559127a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=379b1559127a, replyNumber=0, likeNumber=60, createdTime=2019-09-30, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=379b1559127a, moduleTitle=Stroke：非瓣膜性心房颤动患者口服抗凝剂的有效性和安全性研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=379b1559127a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819479, encodeId=25c018194e916, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=Diabetic Med：利伐沙班与华法林治疗非瓣膜性心房颤动和糖尿病患者的有效性和安全性, objectType=article, longId=152527, objectId=351015252e50, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=351015252e50, replyNumber=0, likeNumber=62, createdTime=2018-12-14, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=351015252e50, moduleTitle=Diabetic Med：利伐沙班与华法林治疗非瓣膜性心房颤动和糖尿病患者的有效性和安全性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=351015252e50)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819478, encodeId=972818194e8f2, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=JAHA：卒中合并非瓣膜性房颤，既往DOAC治疗有哪些益处？, objectType=article, longId=148742, objectId=9ccd148e4298, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ccd148e4298, replyNumber=0, likeNumber=79, createdTime=2019-01-27, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ccd148e4298, moduleTitle=JAHA：卒中合并非瓣膜性房颤，既往DOAC治疗有哪些益处？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9ccd148e4298)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819481, encodeId=15ff1819481e8, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=Circulation：非瓣膜性房颤患者围手术期抗凝：DOACs vs华法林, objectType=article, longId=153169, objectId=dfd415316946, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfd415316946, replyNumber=0, likeNumber=69, createdTime=2019-09-08, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfd415316946, moduleTitle=Circulation：非瓣膜性房颤患者围手术期抗凝：DOACs vs华法林, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=dfd415316946)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819476, encodeId=39bb18194e60d, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=Circulation：非瓣膜性房颤患者：NOAC与VKA谁是阿司匹林的更佳拍档？, objectType=article, longId=134289, objectId=c5a613428989, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5a613428989, replyNumber=0, likeNumber=74, createdTime=2018-09-25, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5a613428989, moduleTitle=Circulation：非瓣膜性房颤患者：NOAC与VKA谁是阿司匹林的更佳拍档？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c5a613428989)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819483, encodeId=910d1819483b9, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=Clin Pharmacol Ther：达比加群vs利伐沙班治疗非瓣膜性房颤标准或降低剂量影响几何？, objectType=article, longId=156509, objectId=fcba1565093c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcba1565093c, replyNumber=0, likeNumber=98, createdTime=2019-10-12, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcba1565093c, moduleTitle=Clin Pharmacol Ther：达比加群vs利伐沙班治疗非瓣膜性房颤标准或降低剂量影响几何？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fcba1565093c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1819480, encodeId=b9a8181948097, content=<a href='/topic/show?id=3d0099539fd' target=_blank style='color:#2F92EE;'>#非瓣膜性#</a>, objectTitle=JAHA：非瓣膜性房颤患者口服抗凝剂类型与痴呆风险的关系, objectType=article, longId=152787, objectId=9f72152e871d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f72152e871d, replyNumber=0, likeNumber=64, createdTime=2019-08-27, rootId=0, userName=gostraight, userId=db5b227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f72152e871d, moduleTitle=JAHA：非瓣膜性房颤患者口服抗凝剂类型与痴呆风险的关系, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9f72152e871d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

非瓣膜性

2020-05-29

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

BMJ：心脏复律可降低新诊断非瓣膜性房颤患者不良预后风险

2022-01-17

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

J Cardiol：非瓣膜性心房颤动合并急性心力衰竭患者使用艾多沙班治疗的D-二聚体水平变化分析

2022-05-27

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

Eur Heart J：非瓣膜性房颤患者持续服用口服抗凝药的预测因子、时间进程和结局

2021-09-19

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

JAHA：血压变异性对非瓣膜性房颤患者不良事件的影响

2021-03-05

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

Br J Clin Pharmacol：非瓣膜性房颤遇上肝病，直接口服抗凝剂的使用和长期疗效

2022-05-20

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

2021 ESC：利伐沙班显著降低肾功能保留的非瓣膜性房颤患者的肾功能下降风险

2022-04-10

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

对于非瓣膜性房颤使用新型抗凝药物的用量如何确定？

2022-04-30

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

JACC：糖尿病前期也可增加非瓣膜性房颤患者的卒中风险

2021-11-12

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

Stroke：非瓣膜性房颤患者卒中发作后早期开始直接口服抗凝药对短期和长期结局的影响

2020-05-31

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

EUR HEART J-CARD PHA：利伐沙班与华法林对非瓣膜性心房颤动和冠状动脉或外周动脉疾病患者的有效性和安全性如何？

2021-07-08

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

2019 ESO指南：卒中或短暂性脑缺血发作以及非瓣膜性房颤患者卒中和其他血栓栓塞事件二级预防抗栓治疗

2019-07-01

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

Chest：非瓣膜性房颤患者四种口服抗凝血剂的有效性和安全性评估

2020-03-22

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

2019ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS适用性标准：非瓣膜性心脏病心脏结构和功能多峰成像评估

2019-06-25

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

Stroke：非瓣膜性心房颤动患者口服抗凝剂的有效性和安全性研究

2019-09-30

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

Diabetic Med：利伐沙班与华法林治疗非瓣膜性心房颤动和糖尿病患者的有效性和安全性

2018-12-14

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

JAHA：卒中合并非瓣膜性房颤，既往DOAC治疗有哪些益处？

2019-01-27

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

Circulation：非瓣膜性房颤患者围手术期抗凝：DOACs vs华法林

2019-09-08

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

Circulation：非瓣膜性房颤患者：NOAC与VKA谁是阿司匹林的更佳拍档？

2018-09-25

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

Clin Pharmacol Ther：达比加群vs利伐沙班治疗非瓣膜性房颤标准或降低剂量影响几何？

2019-10-12

gostraight (审核中...)

前往app查看评论内容

#非瓣膜性#

JAHA：非瓣膜性房颤患者口服抗凝剂类型与痴呆风险的关系

2019-08-27

科室
- - 订阅+
  - 更多科室
工具
服务